- 94991 39337
- zydrabiotech@gmail.com
ZYDRA BIOTECH South Africa
Working for a long Zydra biotech had established itself as a major player in pharmaceuticals industry in South Africa. Zydra biotech is among the top most desirable pharmaceuticals organization in the field of manufacturing , with 100 % innovation, market research, world class R&D
Here drugs are processed with only premium ingredients, under the strict inspection of our quality control expert’s team. We grantee that our quality products are among the best in pharmaceuticals industry, make us gained the trust of top doctors and their indiscriminately trust.
About us
Welcome to ZYDRA BIOTECH INDIA
Launching to INDIA with our INDIA CEO Mrs. A.K.CHOPRA, we have established a state of art facility, where we installed latest technology and tools. We adhere to environment protection protocols and process our drugs in an Eco-friendly unit. We have vowed to employ only highly qualified chemists and pharmaceutical vendors who have been shortlisted on the basis of their credibility and past track record. Also, our drugs are clinically examined by a team of experts, who follow guidelines laid out by the Indian Medical Association (IMA).
Our Mission Is To
Develop and commercialize safe, effective, and high-quality pharmaceutical products at a reasonable cost
Be patient focused and provide the highest level of patient support and service
Conduct all business with honesty, professionalism, and integrity
Maximize internal talent by hiring, training, and retaining the very best employees
Our Directors
Dr. Tomas Zydra
Chairman & Managing Director
Blanche Tempest
Independent Director
Cristiana Huddec
Executive Director –Corporate services
Sheryl Johan
Executive Director & Chief financial Officer
A.K.Chopra
Indian CEO
Monica Balm
Independent Director
Changing the course of Autoimmune disease
ZYDRA BIOTECH exists to make a difference. Our mission is to transform people’s lives by delivering therapeutics that changes the course of autoimmune disease. From the earliest days of the company, we’ve applied a creative, thoughtful and responsible approach to developing therapies for people in need.
In addition to driving adoption of our approved therapy for appropriate people, we are also actively pursuing a broader portfolio of innovative drugs for autoimmune disease.
Our strategy leverages the skills and knowledge of our incredible team and our deep experience in principled drug development and commercialization. Together, we are driven to make an impact for our patient communities as advocates and partners in innovation.